What does a Trump presidency mean for oncology research?

1st January, 1970

What does a Trump presidency mean for oncology research?

On the 20th January, Trump assumed office of the United States of America. 2 months following the election results, high levels of uncertainty still spread across not only the United States but the whole world. What plans did Trump have? Why did he not mention research funding during his campaign? What did Trump’s immigration law changes have in store? Various questions were left floating around the clinical trial industry.

In 2016, it was estimated that approximately 1,685,210 new cases of cancer would be diagnosed, resulting in more than half a million deaths within the States. It was in 1971 that the then U.S. President Richard Nixon signed the National Cancer Act – a major point in our history and our fight against one of the leading causes on premature death. Over the past years, we have seen a massive incline in cancer deaths yet as a global community, we strive to fight back. Will Trump stand in the way of this?


The Trump Immigration Ban

Trump’s immigration ban is just one policy that has the ability and potential to threaten the work that the country has invested so much time in – with the help from talented individuals from all corners of the world.  This pool of innovative thinkers allows new engines of thought and methods that cannot be translated from doctors and scientists who have all trained within the U.S. Combining our research with other countries is the only way that we can outrun the growth of cancer and various other threatening diseases.


Will Trump fund and support medical research?

A topic that was never covered during Trump’s election campaign is whether he would invest in clinical research. We are still yet to discover the affects that a Trump presidency will have on the industry over the next 4 years and there are various contrasting opinions regarding the subject. Some suggest that he will but back on funding given after statements surrounding Obama’s proposed cancer moonshot funding were made by members of Trump’s committee. Trump also once suggested that he was not against providing extra funding however he was fully aware that funding in other areas had to be decreased in order for this to be actionable. Despite all the fear that scientists face, others keep their hopes high that Trump will not block a milestone that the whole world is working towards.


Are you interested in sharing your thoughts on how a Trump presidency will affect the industry? Contact us today to attend Clinical Operation in Oncology Trials East Coast 2017 as a speaker and share your first-hand experience of the changes that are happening.

Register here today to join the discussion >>



Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the

If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:

Paul Adams
+44 (0)20 7936 6948

Speaker opportunities

We identify and invite individuals we believe to be the best speakers in the market, if you think you can make a difference to the quality of our events please contact:

Chloe Roberts
E: Chloe.Roberts@arena-international.com
T: +44 (0)207 936 6822